When treating chronic lymphocytic leukemia (CLL), oncologists and hematologists will often encounter challenges related to uncertainty about the best approach to therapy, or a disease course bare of good options. Examples include strategies for relapsed disease in either the post-chemoimmunotherapy or post-ibrutinib setting, and management of patients who develop diffuse large B-cell lymphoma (DLBCL) after Richter’s transformation.
The following three-question quiz will test one aspect from each article in this “Clinical Challenges” series. Correct answers and explanations will appear after completing the quiz.
1969-12-31T19:00:00-0500
last updated
Source: MedicalNewsToday.com
